ArticleParasites & vectors2025
Striking tick-borne virus diversity and potential reservoirs documented during One-Health-based cross-sectional screening in Anatolia.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Benchmarks for taxonomic classification of jingmenviruses and closely related viruses using newly identified genomic sequences.The Journal of general virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn expansion of recently described human pathogenic tick-borne viruses from Central Asia toward Europe has been documented. Located on important bird migration routes, Anatolia is an intercontinental crossing hub with various climactic zones and with an abundance of endemic tick species. We sought to investigate tick-borne viruses utilizing a One Health approach encompassing host-removed ticks and host samples.
methodsWe collected host-attached ticks and accompanying plasma in 2023-2024 at locations in 20 provinces representing the 7 distinct geographical regions in Anatolia. The hosts comprised cattle, sheep, dogs, goats, and tortoises. The ticks were morphologically identified, processed in pools, and these pools, along with plasma from cattle, sheep and goats, were subjected to nucleic acid purification and complementary DNA synthesis. Viruses were screened by generic (nairovirus) and specific (Jingmen tick virus, JMTV; Tacheng tick virus 1, TcTV-1; Tacheng tick virus 2, TcTV-2; and Tamdy virus, TAMV) amplification assays and characterized by sequencing.
resultsA total of 93 animal plasma samples and 1265 samples from 11 tick species were screened in 192 pools. Crimean-Congo hemorrhagic fever virus (CCHFV) was detected in five tick species in ten pools (5.2%). Three distinct virus lineages, including Europe 1 and 2, as well as Africa 1, were noted. TcTV-1 was identified in 6 tick species in 12 pools (6.3%) and in a cattle plasma sample. Analysis of the nucleoprotein-encoding sequences revealed two separate virus clades, distinct from those reported from Asia and Europe. TAMV was identified in two tick species (1%). We further detected JMTV in 7 pools (3.6%), with sequences forming a new clade phylogenetically closer to viruses of Asian origin than local strains. Finally, highly divergent sequences of a novel nairovirus, forming a distinct group sharing ancestors with TcTV-1, TAMV, and pangolin/tick-associated nairoviruses, was observed in four pools (2%), comprising Haemaphysalis parva ticks.
conclusionsWe described a previously undocumented diversity of tick-borne viral pathogens, CCHFV, TcTV-1, and JMTV, in Anatolia. Possible animal reservoirs of TcTV-1 were identified. These pathogens and TAMV should be considered in the diagnostic workup of cases with symptoms associated with tick bites and in future surveillance efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.